Literature DB >> 20184695

Spectral domain optical coherence tomography guided photodynamic therapy for choroidal hemangioma: a case report.

Kakarla V Chalam1, Ravi K Murthy, Shailesh K Gupta, Vikram S Brar.   

Abstract

INTRODUCTION: Circumscribed choroidal hemangiomas are vascular tumors associated with secondary changes in the overlying retinal pigment epithelium and neuro-sensory retina. Spectral-domain optical coherence tomography, a recent advancement in fundus imaging techniques provides high resolution images of the retina. We describe spectral domain Optical coherence tomography findings in a case of circumscribed choroidal hemangioma which was successfully treated with photodynamic therapy. CASE
PRESENTATION: A 41-year-old white male presented with decreased vision in his right eye. Fundus evaluation showed findings consistent with circumscribed choroidal hemangioma. Spectral-domain optical coherence tomography revealed a large serous retinal detachment overlying the tumor with an intact photoreceptor layer. The patient underwent photodynamic therapy and a repeat tomography scan confirmed the resolution of serous detachment with return of normal foveal contour.
CONCLUSION: Spectral domain optical coherence tomography is an emerging modality in imaging of the retina and reveals ultrastructural changes occurring in various retina pathologies. In this case report we illustrate the use of spectral domain optical coherence tomography for the first time to document retinal changes overlying a choroidal hemangioma and its role as a non-invasive tool in planning the treatment and prognosticating the final visual outcome following treatment for circumscribed subfoveal choroidal hemangiomas.

Entities:  

Year:  2009        PMID: 20184695      PMCID: PMC2827056          DOI: 10.1186/1757-1626-0002-0000008778

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  8 in total

1.  Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results.

Authors:  Ursula M Schmidt-Erfurth; Stephan Michels; Christine Kusserow; Bernhard Jurklies; Albert J Augustin
Journal:  Ophthalmology       Date:  2002-12       Impact factor: 12.079

Review 2.  Transpupillary thermotherapy in the management of circumscribed choroidal hemangioma.

Authors:  Kaan Gündüz
Journal:  Surv Ophthalmol       Date:  2004 May-Jun       Impact factor: 6.048

3.  Photodynamic therapy of circumscribed choroidal hemangioma.

Authors:  Giulio Porrini; Alfonso Giovannini; Giampaolo Amato; Alfonso Ioni; Marco Pantanetti
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

4.  Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases.

Authors:  C L Shields; S G Honavar; J A Shields; J Cater; H Demirci
Journal:  Ophthalmology       Date:  2001-12       Impact factor: 12.079

5.  Circumscribed choroidal hemangioma: characteristic features with indocyanine green videoangiography.

Authors:  J F Arevalo; C L Shields; J A Shields; P G Hykin; P De Potter
Journal:  Ophthalmology       Date:  2000-02       Impact factor: 12.079

Review 6.  Photodynamic therapy of circumscribed choroidal haemangioma.

Authors:  A D Singh; P K Kaiser; J E Sears; M Gupta; P A Rundle; I G Rennie
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

Review 7.  Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature.

Authors:  H Witschel; R L Font
Journal:  Surv Ophthalmol       Date:  1976 May-Jun       Impact factor: 6.048

8.  Spectral-domain optical coherence tomography with multiple B-scan averaging for enhanced imaging of retinal diseases.

Authors:  Atsushi Sakamoto; Masanori Hangai; Nagahisa Yoshimura
Journal:  Ophthalmology       Date:  2007-12-03       Impact factor: 12.079

  8 in total
  1 in total

Review 1.  Clinical applications of spectral domain optical coherence tomography in retinal diseases.

Authors:  R K Murthy; Shamim Haji; Kumar Sambhav; Sandeep Grover; K V Chalam
Journal:  Biomed J       Date:  2016-06-20       Impact factor: 4.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.